$CLVS News Article - Clovis Oncology Announces Interim Results from Rubraca (rucaparib) Phase 2 Study in Advanced Pancreatic Cancer and Nonclinical Data in Multiple Solid Tumor Types for Rucaparib and Lucitanib Presented at AACR 2019
https://marketwirenews.com/news-releases/clov...32146.html